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Successful treatment of an iatrogenic right hepatic
artery pseudoaneurysm and stenosis with a
stent graft
Jared R. Hylton, MS, and William C. Pevec, MD, Sacramento, Calif
A 53-year-old woman presented with an iatrogenic right hepatic artery pseudoaneurysm after a laparoscopic cholecys-
tectomy. Approximately 1 year after the cholecystectomy, liver transaminases were elevated, and she complained of
recurrent “crampy” right upper quadrant pain that radiated posteriorly to her back. Imaging studies demonstrated an
aneurysm or pseudoaneurysm of the hepatic artery at the porta hepatis, with possible infiltration into the parenchyma
between the right and left lobes of the liver. Selective celiac arteriography showed a 90% stenosis of the right hepatic artery
with a large pseudoaneurysm arising from the stenotic segment. This was treated with a 3- 16-mm stent graft (Jostent;
Abbott Vascular, Temecula, Calif) with good result. The completion arteriogram showed wide patency of the stent graft
with total exclusion of the pseudoaneurysm. Follow-up serial duplex scans up to 40 months after the procedure showed
no evidence of residual pseudoaneurysm and wide patency of the stent graft, with no evidence of focal velocity changes in
the right hepatic artery. The patient continues to do well clinically. ( J Vasc Surg 2010;51:1510-3.)Although rare, iatrogenic pseudoaneurysms of the he-
patic arteries are encountered more frequently due to lapa-
roscopic biliary procedures and percutaneous hepatic inter-
ventions. Endovascular therapy using coil embolization has
emerged as the treatment of choice for most of these
pseudoaneurysms. However, in some cases, coil emboliza-
tion will result in hepatic artery occlusion, which is not
always well tolerated. We report the case of a post-chole-
cystectomy iatrogenic pseudoaneurysm of the right hepatic
artery associated with a tight stenosis of the right hepatic
artery, with both the pseudoaneurysm and stenosis success-
fully treated with a covered stent.
CASE REPORT
A 53-year-old woman with a history of hypertension and
smoking was admitted for cholecystitis and underwent a laparo-
scopic cholecystectomy in 2005. Her immediate postoperative
course was unremarkable. Approximately 1 year later, she pre-
sented to her physician with complaints of crampy right upper
quadrant pain that radiated to her back and described the pain as
similar to that associated with her prior gallbladder disease. Nota-
ble laboratory studies included total serum levels of bilirubin of 1.8
mg/dL, aspartate aminotransferase of 432 U/L, and alanine ami-
notransferase of 369 U/L.
Ultrasound imaging showed an aneurysm of the hepatic ar-
tery. A computed tomography (CT) scan demonstrated a 4.0- 
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15102.3-  2.0-cm aneurysm or pseudoaneurysm of the hepatic artery
at the porta hepatis, with possible extension into the parenchyma
of the liver between the right and left lobes (Fig 1). Magnetic
resonance imagining (MRI) confirmed a pseudoaneurysm that
measured 3.2  2.2  2.1 cm. The aorta, superior mesenteric
artery, and renal arteries all appeared normal, as did all of the other
imaged arteries and veins, on both the CT and MRI scans.
The patient was referred for management of the pseudoaneu-
rysm. She denied jaundice or acholic stool, and review of systems
was unremarkable. On physical examination, no right upper quad-
rant mass or tenderness was detected.
The hepatic pseudoaneurysm was thought to be iatrogenic,
the result of an occult arterial injury at the time of the cholecystec-
tomy. The decision was made to proceed with aortography, celiac
arteriography, and hepatic arteriography for further investigation
and management of the pseudoaneurysm. The plan was to occlude
the pseudoaneurysm with embolization coils.
Selective celiac arteriography, using a 5F SOS Omni catheter
(AngioDynamics Queensbury, NY), showed a hepatic artery pseu-
doaneurysm, but the artery of origin was not clear (Fig 2). Heparin
was administered, and the SOSOmni catheter was exchanged over
a 0.035-inch angled Terumo Glidewire (Terumo Medical Corp,
Somerset NJ) for a 5F angled Terumo Glidecatheter. This was
successfully guided into the hepatic artery and then into the right
hepatic artery. Subselective right hepatic arteriography demon-
strated a 90% stenosis of the right hepatic artery, with a large
pseudoaneurysm arising from the stenotic segment (Fig 3).
Embolization of the pseudoaneurysm would likely have re-
sulted in occlusion of the right hepatic artery. In an attempt to
preserve flow in the right hepatic artery, while excluding the
pseudoaneurysm from arterial flow, a decision was made to treat
both the stenosis and the pseudoaneurysm with a covered stent. A
6F AL 0.75 guiding catheter (Cordis Corporation, Warren, NJ)
was advanced into the proximal celiac axis. The stenotic segment of
the right hepatic artery was successfully crossed with a 0.014 PT
Graphix guidewire (Boston Scientific, Natick, Mass) through a
0.014-inch Quick-Cross catheter (Spectranetics, Colorado
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catheter to confirm positioning, a 3-  16-mm Jostent GraftMas-
ter stent graft (Abbott Vascular, Temecula, Calif) was inflated to
12 atm across the stenotic segment of the right hepatic artery,
covering the orifice of the pseudoaneurysm. The stent graft was
postdilated with a 3-  9-mm NC Ranger balloon (Boston Scien-
tific Scimed, Maple Grove, Minn), inflated to 18 atm in the
proximal and distal stent graft. A completion arteriogram through
a 0.035-inch Quick-Cross catheter showed wide patency of the
right hepatic artery, with complete exclusion of the pseudoaneu-
rysm (Fig 4). The patient was discharged to home on the same day,
with a regimen of aspirin and clopidogrel, without complication.
The patient has had no recurrent abdominal pain. Serial du-
plex scans, at 2, 8, 12, 18, 28, and 40 months have shown a patent
right hepatic artery without stenosis, wide patency of the stent graft
with no stenosis, and no evidence of pseudoaneurysm (Fig 5). No
focal velocity changes have been noted in the stent graft or in the
Fig 1. A computed tomography scan of the abdomen shows the
pseudoaneurysm (arrow) at the porta hepatis.
Fig 2. A selective celiac arteriogram shows the hepatic artery
pseudoaneurysm (PSA). The origin of the pseudoaneurysm is not
clear. CHA, Common hepatic artery; GDA, gastroduodenal ar-
tery; PHA, proper hepatic artery; SA, splenic artery.right hepatic artery.DISCUSSION
Although iatrogenic pseudoaneurysms complicating
cholecystectomy are relatively rare, an increase in the inci-
dence of hepatic artery pseudoaneurysm has been attrib-
uted to laparoscopic surgery, percutaneous liver proce-
dures, and aggressive pancreatic surgery.1 The reported
incidence of iatrogenic hepatic artery pseudoaneurysm is
highest after laparoscopic cholecystectomy.2 A large multi-
center analysis reported iatrogenic vascular injuries associ-
ated with laparoscopic cholecystectomy at a rate of 0.25%,
whereas other sources reported arterial injuries at a rate of
0.2% to 0.5%.3,4 Specifically, right hepatic artery pseudoa-
neurysms occur in up to 0.6% of patients after laparoscopic
cholecystectomy,5 and 85% of iatrogenic hepatic artery
Fig 3. A subselective right hepatic arteriogram shows the pseu-
doaneurysm (black arrow) arising from the right hepatic artery,
associated with a 90% stenosis (white arrow) of the right hepatic
artery.
Fig 4. A completion right hepatic arteriogram shows the success-
ful treatment of the stenosis and pseudoaneurysm with a 3- 
16-mm stent graft (between the arrows).pseudoaneurysms involved the right hepatic artery.4
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acute emergency. They have a propensity to enlarge and
rupture at a rate of 20% to 80%.2,6,7 Rupture is associated
with a 21% to 43% mortality rate,2,7,8 and thus, pseudoan-
eurysms of the hepatic arteries should be treated aggres-
sively and without delay.
The treatment of choice for hepatic artery pseudoaneu-
rysms is coil embolization. Embolization is associated with
a lower rate of mortality and morbidity than surgical inter-
vention,1 but surgical ligation or excision is an option when
coil embolization fails or patients have coexisting condi-
tions that require surgical intervention or militate against
an endovascular approach.
Pseudoaneurysms of the right hepatic artery can be
treated by completely occluding the right hepatic artery
with coils or by filling the pseudoaneurysm cavity with coils,
maintaining patency of the right hepatic artery. Coil occlu-
sion of the right hepatic artery is associated with a number
of risks. After occlusion of the right hepatic artery, intrahe-
patic translobar collaterals typically re-establish arterial flow
and prevent infarction of the right hepatic lobe.9 The collat-
eral circulation is not always sufficient, however, and hepatic
infarction and necrosis have been reported as a complication
of hepatic artery embolization.10-12 Other complications in-
clude recanalization of the vessel, requiring repeat emboliza-
tion or surgical intervention, migration of coils,6,12 and coil
erosion into the common bile duct.13 The alternative ap-
proach of embolization of the pseudoaneurysm cavity itself
has the advantage of maintaining blood flow through the
hepatic artery but is more technically challenging and can
result in incomplete ablation of the pseudoaneurysm or
occlusion of the hepatic artery.
Recently, several cases have been reported of successful
stent graft treatment of hepatic artery pseudoaneurysms.14-17
Like coil embolization, the use of stent grafts is minimally
invasive and associated with lower rates of morbidity and
Fig 5. B-mode ultrasound (left) and color duplex ultrasound
(right) images show the stent graft (between the arrows) in the
right hepatic artery.death compared with open surgical management. Thistechnique has the advantage of maintaining arterial blood
flow, maintaining perfusion of the liver, and minimizing
the risk of ischemia seen with coil embolization.
Currently available self-expanding stent grafts include
the Bard Fluency (Bard Peripheral Vascular, Tempe, Ariz),
with a minimum device diameter of 6 mm, and the Gore
Viabahn (W. L. Gore and Associates, Flagstaff, Ariz), which
has a minimum device diameter of 5 mm. The Atrium
iCAST (Atrium Medical Corp, Hudson, NH) is a balloon-
expandable stent graft with a minimum product diameter
of 5 mm. Although any of these might be an option in the
treatment of larger-diametermain visceral artery trunks, the
choices for covered stent grafts for use in small visceral
artery branches are very limited. The Abbott Jostent Graft-
Master comes in diameters from 3.0 to 5.0 mm, at 0.5-mm
increments, and in lengths of 12 to 26 mm. This balloon-
expandable stainless stent with a polytetrafluoroethylene
covering is approved only for humanitarian use in the
treatment of free perforations of coronary arteries or coro-
nary grafts; other uses require the user to file for an exemp-
tion, which was done in this case.
The reported case was unique in a number of ways.
Although the right hepatic artery is reported to be the most
common site for formation of an iatrogenic pseudoaneu-
rysm after laparoscopic cholecystectomy, we are aware of
only one report that addressed the management of right
hepatic artery pseudoaneurysm with an endovascular stent
graft.15 Management of a pseudoaneurysm in the right
hepatic artery is considered more technically challenging
than in other branches of the hepatic vasculature due to its
relatively distal location, smaller diameter, and often con-
torted, complex anatomy.
The right hepatic artery stenosis in association with the
pseudoaneurysm added to the complexity of this case.
Subselective arteriography showed 90% stenosis of the right
hepatic artery, with the pseudoaneurysm arising from
the stenotic segment. A comprehensive literature review
yielded no other report of a case of arterial stenosis compli-
cating an iatrogenic right hepatic artery pseudoaneurysm.
The serial duplex follow-up of our patient provides
documentation of the midterm patency and therapeutic
efficacy of the stent graft in the right hepatic artery. Duplex
ultrasound imaging at 2, 8, 12, 18, 28, and 40 months
postoperatively has shown wide patency of the stent graft,
with total exclusion of the pseudoaneurysm. No focal ve-
locity changes have been noted in the stent graft or the
right hepatic artery, and the patient continues to do well
clinically. This is unique in that a literature search found
only one other report that provided duplex follow-up for
management of a pseudoaneurysm in the right hepatic
artery.15
In general, stent graft patency is better in arteries with
larger diameters and those with high flow rates. The hepatic
arteries have a small diameter but have relatively high rates
of flow, analogous to the coronary arteries. Thus, the
prognosis for patency should be fairly good. Additional
cases with careful duplex ultrasound imaging and clinical
follow-up are needed to determine if stent graft treatment is
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neurysms.
CONCLUSION
Iatrogenic right hepatic artery pseudoaneurysms are
rare but carry a high mortality rate if not successfully
managed in a timely manner. Various surgical and endovas-
cular modalities are available for the treatment of pseudoa-
neurysms. The outcome of this case supports the notion
that endovascular stent grafting is an effective and safe
option for the treatment of pseudoaneurysms of the right
hepatic artery. The stent graft provided occlusion of the
pseudoaneurysm and maintained patency of the vessel,
lowering the risk of ischemia and infarction of the liver. In
addition, this case shows that stent grafting is effective in
managing hepatic artery pseudoaneurysms with associated
stenosis, a condition not previously described in the litera-
ture, to our knowledge. Lastly, the careful duplex ultra-
sound follow-up suggests that stent grafting is a viable
solution, at least in the midterm. Despite the promising
outcome of this patient, additional long-term data are
needed to establish the role of stent grafting in the treat-
ment of hepatic artery pseudoaneurysm and stenosis.
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